Iktos was founded in 2016 by Quentin Perron, Nicolas Do Huu, and Yann Gaston-Mathé, with the aim of developing an innovative and user-friendly technology platform for deep-learning based de novo drug design, leveraging a proprietary algorithm developed by Quentin and Nicolas who initially wanted to apply to chemistry the deep learning generative models previously used in fields such as image and natural language processing.
...
Iktos was founded in 2016 by Quentin Perron, Nicolas Do Huu, and Yann Gaston-Mathé, with the aim of developing an innovative and user-friendly technology platform for deep-learning based de novo drug design, leveraging a proprietary algorithm developed by Quentin and Nicolas who initially wanted to apply to chemistry the deep learning generative models previously used in fields such as image and natural language processing.
Since that time, academic and industry publications in the field of deep learning for drug design have flourished.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.